RECRUITING

Sleep Length and Euploid Embryo Transfer Prospective Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Sleep is a critical component of daily life that significantly influences health and well-being. Despite the integral role sleep plays in life, its effect on women's reproductive health, and its subsequent impact on fertility, is largely understudied. The purpose of the SLEEP Study is to investigate the link between sleep and fertility. Participants will use a wireless wearable device mounted on the finger to measure sleep in the weeks preceding and following an embryo transfer during treatment with in vitro fertilization. The investigators hope that these findings will inform future therapies that improve sleep and fertility outcomes.

Official Title

Sleep Length and Euploid Embryo Transfer Prospective Study

Quick Facts

Study Start:2024-01-17
Study Completion:2025-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06139757

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Undergoing a single euploid frozen embryo transfer
  2. * Patient's 1st, 2nd, or 3rd embryo transfer (prior fresh or frozen transfers included)
  1. * Primary infertility diagnosis of polycystic ovary syndrome
  2. * BMI \> 40
  3. * Diagnosis of primary ovarian insufficiency (FSH \> 40)
  4. * Night work
  5. * High risk of poor outcomes of fertility treatment \[\> 2 prior miscarriages (women with recurrent pregnancy loss), significant uterine factor infertility \[\>/= 2 myomectomies (open abdominal or laparoscopic) or any non-hystoeroscopic myomectomy entering the endometrial cavity\]
  6. * Undergoing medical fertility preservation for a significant medical co-morbidity
  7. * Current cancer diagnosis
  8. * \> 3 prior failed embryo transfers in attempt for current live birth

Contacts and Locations

Study Contact

Sarah C Cromack, MD
CONTACT
312-926-8244
sarah.capelouto@nm.org
Jessica Walter, MD
CONTACT
312-926-8244
jessica.walter@nm.org

Principal Investigator

Jessica Walter, MD, MSCE
PRINCIPAL_INVESTIGATOR
Northwestern University

Study Locations (Sites)

Northwestern Memorial Hospital
Chicago, Illinois, 60611
United States

Collaborators and Investigators

Sponsor: Northwestern University

  • Jessica Walter, MD, MSCE, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-17
Study Completion Date2025-07-31

Study Record Updates

Study Start Date2024-01-17
Study Completion Date2025-07-31

Terms related to this study

Keywords Provided by Researchers

  • wearable
  • sleep

Additional Relevant MeSH Terms

  • Infertility, Female